Publicacions en col·laboració amb investigadors/es de Hospital Ramón y Cajal (16)

2024

  1. A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

    Frontiers in Immunology, Vol. 15

  2. Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis

    International Journal of Molecular Sciences, Vol. 25, Núm. 18

2023

  1. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

  2. Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in Immunology, Vol. 14

2022

  1. Epstein-Barr Virus Load Correlates with Multiple Sclerosis-Associated Retrovirus Envelope Expression

    Biomedicines, Vol. 10, Núm. 2

  2. Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients

    Biology, Vol. 11, Núm. 11

  3. Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study

    European Journal of Neurology, Vol. 29, Núm. 3, pp. 895-900

2021

  1. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression

    Frontiers in Immunology, Vol. 12

  2. Evolution of antibody titres against Epstein–Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients

    Scientific Reports, Vol. 11, Núm. 1

  3. Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

    Frontiers in Immunology, Vol. 12

2020

  1. Acetate correlates with disability and immune response in multiple sclerosis

    PeerJ, Vol. 8

  2. Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

    Scientific Reports, Vol. 10, Núm. 1

  3. Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients

    European Journal of Immunology, Vol. 50, Núm. 5, pp. 685-694

2019

  1. Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study

    European Journal of Neurology, Vol. 26, Núm. 9, pp. 1200-1204

2018

  1. Blood lymphocyte subsets identify optimal responders to IFN-beta in MS

    Journal of Neurology, Vol. 265, Núm. 1, pp. 24-31

  2. Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS (J Neurol, 10.1007/s00415-017-8625-6)

    Journal of Neurology